Literature DB >> 31539270

Curcumin Promoted miR-34a Expression and Suppressed Proliferation of Gastric Cancer Cells.

Chunlin Sun1, Shuping Zhang2, Changhai Liu1, Xueqiang Liu1.   

Abstract

Background: To investigate the effects of curcumin on miR-34a and proliferation of gastric cancer cells. Materials and
Methods: Human gastric cancer cell line SGC-7901 was divided into control, curcumin, miR-34a agomir (miR-34a), miR-34a agomir negative control, and curcumin combined miR-34a antagomir (combine) groups. 3-(4, 5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide assay, scratch damage test, and transwell assay were used to detect cell proliferation, migration, and invasion. The cell apoptosis and cell cycle were detected by flow cytometry. Western blot was used to detect the expression of B-cell lymphoma-2 (Bcl-2), cyclin-dependent kinase 4 (CDK4), and cyclin D1. Terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling was used to detect apoptosis of tumors and Western blot was used to detect the expression of Bcl-2, CDK4, and cyclin D1 in tumors.
Results: The results showed that curcumin markedly increased the content of miR-34a microRNA (mRNA) in SGC-7901 cells, inhibited proliferation, migration, and invasion of SGC-7901 cells, when compared to control group (p < 0.05). Compared with control group, curcumin significantly inhibited cell cycle progression in G0/G1-S phase, increased the cell number of G0/G1 phase, and downregulated the Bcl-2, CDK4, and cyclin D1 protein expression in cells and tissues (p < 0.05). After transfection of miR-34a agomir or antagomir into cells it was found that miR-34a agomir and curcumin had similar effects on resisting malignant biological behavior. Curcumin combined with miR-34a antagomir could weaken or reverse the above results. Conclusions: Curcumin could inhibit the proliferation and induce apoptosis of SGC-7901 cells. Its mechanism might be related to the miR-34a expression in cells, thus affecting the expression of Bcl-2, CDK4, and cyclin D1.

Entities:  

Keywords:  apoptosis; curcumin; gastric cancer; miR-34a

Mesh:

Substances:

Year:  2019        PMID: 31539270     DOI: 10.1089/cbr.2019.2874

Source DB:  PubMed          Journal:  Cancer Biother Radiopharm        ISSN: 1084-9785            Impact factor:   3.099


  22 in total

1.  Curcumin Activates ROS Signaling to Promote Pyroptosis in Hepatocellular Carcinoma HepG2 Cells.

Authors:  Wan-Feng Liang; Yi-Xi Gong; Hai-Feng Li; Fu-Liang Sun; Wei-Long Li; Dong-Qin Chen; Dan-Ping Xie; Chen-Xi Ren; Xiao-Yu Guo; Zi-Yi Wang; Taeho Kwon; Hu-Nan Sun
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

Review 2.  Updated Review on the Role of Curcumin in Gastrointestinal Cancers.

Authors:  Melika Naji; Setareh Soroudi; Maryam Akaberi; Amirhossein Sahebkar; Seyed Ahmad Emami
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Anti-Cancer Effects of Dietary Polyphenols via ROS-Mediated Pathway with Their Modulation of MicroRNAs.

Authors:  Yasukiyo Yoshioka; Tomokazu Ohishi; Yoriyuki Nakamura; Ryuuta Fukutomi; Noriyuki Miyoshi
Journal:  Molecules       Date:  2022-06-14       Impact factor: 4.927

Review 4.  A review on the role of cyclin dependent kinases in cancers.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Peixin Dong; Nikolaus Gassler; Mohammad Taheri; Aria Baniahmad; Nader Akbari Dilmaghani
Journal:  Cancer Cell Int       Date:  2022-10-20       Impact factor: 6.429

5.  Effect of Probucol on Proliferation of Leukemia, Multiple Myeloma, Lymphoma, and Fibroblast Cells.

Authors:  Aslı Koç; Arzu Zeynep Karabay; Ali Yaprak; Zeliha Büyükbingöl; Fügen Aktan
Journal:  Turk J Pharm Sci       Date:  2021-02-25

6.  Curcumin-Induced DNA Demethylation in Human Gastric Cancer Cells Is Mediated by the DNA-Damage Response Pathway.

Authors:  Ruiying Tong; Xian Wu; Ying Liu; Yang Liu; Jigang Zhou; Xinying Jiang; Li Zhang; Xiaoying He; Libing Ma
Journal:  Oxid Med Cell Longev       Date:  2020-06-17       Impact factor: 6.543

Review 7.  Polychemotherapy with Curcumin and Doxorubicin via Biological Nanoplatforms: Enhancing Antitumor Activity.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Farid Hashemi; Amirhossein Zabolian; Hossein Saleki; Morteza Bagherian; Negar Azami; Atefe Kazemzade Bejandi; Kiavash Hushmandi; Hui Li Ang; Pooyan Makvandi; Haroon Khan; Alan Prem Kumar
Journal:  Pharmaceutics       Date:  2020-11-11       Impact factor: 6.321

8.  Curcumin inhibits prostate cancer progression by regulating the miR-30a-5p/PCLAF axis.

Authors:  Liang Pan; Jian Sha; Wenyao Lin; Yuxiong Wang; Tingzhang Bian; Jianming Guo
Journal:  Exp Ther Med       Date:  2021-07-07       Impact factor: 2.447

9.  Clinical effects of curcumin in enhancing cancer therapy: A systematic review.

Authors:  Kamran Mansouri; Shna Rasoulpoor; Alireza Daneshkhah; Soroush Abolfathi; Nader Salari; Masoud Mohammadi; Shabnam Rasoulpoor; Shervin Shabani
Journal:  BMC Cancer       Date:  2020-08-24       Impact factor: 4.430

Review 10.  miRNAs and Novel Food Compounds Related to the Browning Process.

Authors:  Silvia Lorente-Cebrián; Katya Herrera; Fermín I Milagro; Juana Sánchez; Ana Laura de la Garza; Heriberto Castro
Journal:  Int J Mol Sci       Date:  2019-11-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.